DelveInsight

View All

Follicle Stimulating Hormone for treatment of Endometriosis

Follicle Stimulating Hormone (FSH) is a glycoprotein secreted by the anterior pituitary, necessary for mammalian reproduction. FSH helps in development and maturation of gonads at puberty, and the hormone acts by binding to FSH receptor. Endometriosis is an extra growth of endometrial tissues in the abdominal cavity...

Find More

Astellas ditches UMN Pharma; J&J, Actelion land on a price; Bayer’s pledge; Biogen to fork over $1.25B-plus

With Flublok at a standstill in Japan, Astellas ditches collaborator UMN Pharma After Japanese regulators turned away the partners’ submission for a new cell-culture flu vaccine, Astellas has pulled the plug on a collaboration with UMN Pharma. UMN said it’s “regrettable” the companies can no longer work together to ...

Find More

Angina Pectoris
Angina Pectoris : Manifestation of Coronary Artery Disease

Angina Pectoris is the most common and disabling cardiovascular disorder syndrome of precordial discomfort caused due to transient myocardial ischemia. A large number of people suffering from myocardial ischemia have developed Angina Pectoris. According to National Heart, Lung and Blood Institute, approximately 7 mi...

Find More

Vasomotor Symptoms of Menopause-Emerging Therapies

Vasomotor symptoms occur when a woman reaches the state of menopause and the ovaries stop producing eggs, resulting in the reduction of secretion of hormones such as estrogen and progesterone. Therapies available for vasomotor symptoms of menopause are hormonal and non-hormonal, where hormone therapy is the most eff...

Find More

Hurry Up! Grab the latest discount offer…

DelveInsight Announces End of the Year Discount on Reports DelveInsight, a Market Research & Business Consulting firm, has announced up to 40% discount offer on its Market Research Reports, starting from 21st November 2016.

Find More

CRISPR gene-editing tested in a person for the first time

  A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical t...

Find More

Aurobindo’s net profit; LLS selects; Eli Lilly secures; DNA vaccine against Zika

Aurobindo Pharma Q2 net profit up 33.53% to Rs. 606 cr Aurobindo Pharma reported 33.53 per cent rise in consolidated net profit to Rs 605.64 crore for the quarter ending September mainly on account of robust formulation sales. The company had posted a net profit after tax, minority interest and share of profit of jo...

Find More

Estrogen Receptor Positive Breast Cancer: Market Outlook

Estrogen Receptor Positive Breast Cancer is the most common type of breast cancer diagnosed in the world. American Cancer Society has found that approximately two out of every three cases of breast cancer are hormone receptor positive. Approximately, 75% of cases of breast cancer are ER- Positive Breast Cancer and t...

Find More

Fresenius Kabi introduced Bivalirudin; Envigo Launches; Mylan’s MAA accepted; Pricing hit pharma

Fresenius Kabi introduced Bivalirudin for Injection Fresenius Kabi announced that it has introduced Bivalirudin for Injection in the United States, which is an anticoagulant, and a generic alternative to Angiomax. Fresenius Kabi’s Bivalirudin was approved by the U.S. Food and Drug Administration in October. The U.S....

Find More

Merck’s Antibody for Clostridium Difficile

Merck provided substantial evidence of safety and effectiveness for the approval of bezlotoxumab in June 2016 to the FDA, and the administration’s Antimicrobial Drugs Advisory Committee voted 10 to 5 with 1 abstention to recommend its approval. In October 2016, bezlotoxumab commercialized as Zinplava, got approved b...

Find More